Exact Mass: 386.0266

Exact Mass Matches: 386.0266

Found 10 metabolites which its exact mass value is equals to given mass value 386.0266, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Quazepam

7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-2,3-dihydro-1H-1,4-benzodiazepine-2-thione

C17H11ClF4N2S (386.0268)


Quazepam is only found in individuals that have used or taken this drug. It is a drug which is a benzodiazepine derivative. It induces impairment of motor function and has hypnotic properties. Quazepam is used to treat insomnia.Benzodiazepines bind nonspecifically to benzodiazepine receptors, which affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

Polyandrocarpamide A

Polyandrocarpamide A

C18H15BrN2O3 (386.0266)


   

Chalybaeizanic acid

Chalybaeizanic acid

C18H10O10 (386.0274)


   

3-[(4-bromophenoxy)methyl]-N-(5-methyl-3-isoxazolyl)benzamide

3-[(4-bromophenoxy)methyl]-N-(5-methyl-3-isoxazolyl)benzamide

C18H15BrN2O3 (386.0266)


   

[5-(2-amino-5-carboxy-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-hydroxy-2,5-dihydrofuran-2-yl]methyl phosphate

[5-(2-amino-5-carboxy-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-hydroxy-2,5-dihydrofuran-2-yl]methyl phosphate

C12H11N4O9P-2 (386.0264)


   

quazepam

quazepam

C17H11ClF4N2S (386.0268)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

n-[2-(3-bromo-4-hydroxyphenyl)ethyl]-2-(1h-indol-3-yl)-2-oxoacetamide

n-[2-(3-bromo-4-hydroxyphenyl)ethyl]-2-(1h-indol-3-yl)-2-oxoacetamide

C18H15BrN2O3 (386.0266)


   

17-hydroxy-4,12-bis(hydroxymethylidene)-7-methyl-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(11),3(8),6,14(18)-tetraene-5,9,13,15-tetrone

17-hydroxy-4,12-bis(hydroxymethylidene)-7-methyl-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(11),3(8),6,14(18)-tetraene-5,9,13,15-tetrone

C18H10O10 (386.0274)


   

(17s)-5,13,17-trihydroxy-7-methyl-9,15-dioxo-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(18),3(8),4,6,11,13-hexaene-4,12-dicarbaldehyde

(17s)-5,13,17-trihydroxy-7-methyl-9,15-dioxo-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(18),3(8),4,6,11,13-hexaene-4,12-dicarbaldehyde

C18H10O10 (386.0274)


   

5,13,17-trihydroxy-7-methyl-9,15-dioxo-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(18),3(8),4,6,11,13-hexaene-4,12-dicarbaldehyde

5,13,17-trihydroxy-7-methyl-9,15-dioxo-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(18),3(8),4,6,11,13-hexaene-4,12-dicarbaldehyde

C18H10O10 (386.0274)